Evidence map›Paper›PMID 36461128›Full record

ArticleTrials2022

Group psychoeducation for persons with bipolar disorder in Rwanda: a study protocol for a randomized controlled trial.

E Musoni-Rwililiza, C J Arnbjerg, C Murekatete, J Carlsson, P Kallestrup, D Gishoma

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04671225 (Psychoeducation for Patients With Bipolar Disorder in Rwanda), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04671225 nacompletednot on this map

Psychoeducation for Patients With Bipolar Disorder in Rwanda

TypeinterventionalSponsorUniversity of AarhusRan2021 to 2022Enrolled154ConditionsBipolar DisorderArmsGroups Psychoeducation, Waiting-list
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

E Musoni-RwililizaCollege of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda. rwimus@gmail.com.ORCID http://orcid.org/0000-0001-6222-5246
C J ArnbjergCollege of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
C MurekateteMental Health Department, University Teaching Hospital of Kigali, Kigali, Rwanda.
J CarlssonCompetence Centre for Transcultural Psychiatry (CTP), Mental Health Centre Ballerup, Ballerup, Denmark.
P KallestrupCenter for Global Health, Department of Public Health, Aarhus University, Aarhus, Denmark.
D GishomaCollege of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.
Aarhus University · DKCentre Hospitalier Universitaire de Kigali · RWUniversity of Copenhagen · DKUniversity of Rwanda · RW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe efficacy of psychoeducation as an add-on treatment to pharmacotherapy is well documented in treating symptoms and in relapse prevention for persons with bipolar disorder in western countries. Yet, no studies on psychosocial interventions for persons with bipolar disorder have been conducted in a low-income country in Africa.

aimTo develop a bipolar group psychoeducation program contextualized to the Rwandese setting, and determine its effect on symptom severity, medical adherence, and internalized stigma.

methodsA culturally adapted guide manual was developed by local mental health professionals, including nurses, psychologists, and medical doctors. In-depth interviews with participants were held prior to and will be held following the intervention to address the cultural aspect of living with bipolar disease and the impact of the program. A two-armed randomized controlled trial has been set up at the tertiary mental health hospitals in Rwanda, with an intervention and a waiting list arm. A sample size of at least 50 in each arm was calculated as a requirement. The study's primary outcome measure will be the difference in relapse rate measured on the Young Mania Rating Scale and Hamilton Depression Scale-17. Differences in mean change on scales for medical adherence and internalized stigma will be secondary outcomes. Data will be analyzed according to the intention-to-treat principle. Participants will be assessed subsequently at baseline, at the end of the intervention period, and three months and 12 months post-intervention. DISCUSSION: This study will be one of the first intervention trials on bipolar disorder in a low-income country. If proven successful in reducing morbidity and increasing the quality of life in persons with bipolar disorder, it is anticipated that the psychoeducation program can be implemented at the district and community level and act as inspiration for other low-resource settings.

trial registrationClinicalTrials.gov NCT04671225. Registered on November 2020.

Indexed as

Bipolar DisorderAfricaHumansPsychosocial InterventionQuality of LifeRandomized Controlled Trials as TopicRwandaBipolar disorderGlobal mental healthLow- and middle-income countriesPsychoeducationPsychosocial interventionsRwanda

Identifiers

PMID36461128
PMCPMC9716550
OpenAlexW4311106832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.